Kelyniam Global, Inc. Announces Revenues Results for the Third Quarter Ended September 30, 2012 and Fourth Quarter of 2012
January 15, 2013 at 08:15 am EST
Share
Kelyniam Global, Inc. announced revenues results for the third quarter ended September 30, 2012 and fourth quarter of 2012. For the third quarter, the company reported revenues of $382,177. This represents almost double the product revenue produced in the second quarter 2012. The company continues to penetrate the custom cranial implant marketplace and has sold implants to medical institutions in more than 20 different states.
For the fourth quarter, the company orders combined with existing custom cranial implant orders propelled revenues to approximately $400,000 for the fourth quarter, exceeding internal expectations of a slow quarter due to multiple holidays and fewer surgeries.
Kelyniam Global, Inc. is a custom design-to-build medical device manufacturing company. The Company specializes in the delivery of cranial implant technologies to neurologically dependent patients. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patientâs computed tomography (CT) data, the Companyâs 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its K-Plans include ke24, ke72 and kp5day. The Companyâs emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours.
KELYNIAM GLOBAL, INC. 
